LGC
BHC icon

Laurel Grove Capital’s Bausch Health BHC Stock Holding History

Laurel Grove Capital’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-21,770
Closed -$3.88M – 96
2015
Q3 		$3.88M Sell
21,770
-815
-4% -$190K 2.22% 11
2015
Q2 		$5.02M Sell
22,585
-1,625
-7% -$360K 2.67% 4
2015
Q1 		$4.81M Hold
24,210
– – 2.57% 7
2014
Q4 		$3.46M Sell
24,210
-3,050
-11% -$410K 1.98% 17
2014
Q3 		$3.58M Buy
27,260
+540
+2% +$64.4K 1.95% 19
2014
Q2 		$3.37M Buy
26,720
+5,420
+25% +$691K 1.87% 22
2014
Q1 		$2.81M Sell
21,300
-250
-1% -$34.2K 1.69% 21
2013
Q4 		$2.53M Buy
21,550
+3,550
+20% +$389K 1.5% 24
2013
Q3 		$1.88M Buy
18,000
+3,700
+26% +$360K 1.24% 27
2013
Q2 		$1.23M Buy
+14,300
New +$1.13M 0.88% 46

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Laurel Grove Capital's BHC Position: Q4 2015 in Review

Laurel Grove Capital sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 21,770 shares — an estimated $3.88M sold.

Laurel Grove Capital first reported a position in BHC in Q2 2013 and held it in 10 quarters. The position peaked at $5.02M in Q2 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Laurel Grove Capital reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Laurel Grove Capital sold 21,770 Bausch Health shares in Q4 2015, an estimated $3.88M.
  • Laurel Grove Capital first reported a position in Bausch Health in Q2 2013 and held it in 10 quarters.
  • Laurel Grove Capital's Bausch Health position peaked at $5.02M in Q2 2015.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Laurel Grove Capital's 13F filing for Q4 2015, filed 15 Jan 2016.